- Report
- August 2025
- 180 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 188 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 196 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 182 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 192 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 193 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 187 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 193 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2026
- 200 Pages
Japan
From €2234EUR$2,490USD£1,911GBP
- Report
- February 2024
- 137 Pages
Global
From €4441EUR$4,950USD£3,799GBP
- Report
- August 2025
- 189 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 199 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 186 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- February 2025
- 153 Pages
Global
From €5338EUR$5,950USD£4,566GBP
- Report
- June 2024
- 150 Pages
Global
From €5338EUR$5,950USD£4,566GBP
- Report
- June 2026
- 118 Pages
Mexico
From €2690EUR$2,999USD£2,302GBP
€3588EUR$3,999USD£3,069GBP
- Report
- October 2024
- 200 Pages
Global
From €3364EUR$3,750USD£2,878GBP
- Report
- May 2024
- 200 Pages
Global
From €3723EUR$4,150USD£3,185GBP
- Report
- March 2024
- 200 Pages
Global
From €3723EUR$4,150USD£3,185GBP
- Report
- March 2024
- 200 Pages
Global
From €3723EUR$4,150USD£3,185GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more